奥泰生物 (688606.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(奥泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 221,522,104.88196,582,470.98199,920,896.28194,758,299.98172,091,295.89151,711,957.82236,135,335.17
 营业收入(元) 221,522,104.88196,582,470.98199,920,896.28194,758,299.98172,091,295.89151,711,957.82236,135,335.17
二、营业总成本(元) 152,175,503.84128,790,068.18144,138,319.97154,229,802.47131,943,848.93126,981,654.51178,928,268.65
 营业成本(元) 95,035,569.4378,691,806.0699,702,324.2494,879,015.6784,560,017.9795,410,611.34111,691,152.72
 研发费用(元) 22,346,142.1326,002,102.2423,156,697.0431,476,380.2323,814,423.2629,756,834.7636,121,641.21
 营业税金及附加(元) 1,195,288.831,528,943.132,049,793.493,335,055.951,106,529.001,003,975.461,591,444.70
 销售费用(元) 11,838,216.0819,234,630.2310,813,141.1421,836,005.3214,805,769.4915,968,514.0516,674,929.87
 管理费用(元) 15,501,197.7716,642,087.4713,493,416.4218,133,633.5813,988,811.3216,293,784.3118,170,533.21
 财务费用(元) 6,259,089.60-13,309,500.95-5,077,052.36-15,430,288.28-6,331,702.11-31,452,065.42-5,321,433.05
  其中:利息费用(元) 105,339.56128,283.61132,558.32280,468.23334,541.80391,284.66442,378.79
  其中:利息收入(元) 381,237.3812,112,108.235,365,092.086,130,922.997,689,680.3413,348,603.448,449,126.99
 资产减值损失(元) 1,071,736.68-2,941,470.64-5,444,901.014,546,497.50-3,725,108.3321,840,649.60-17,060,829.32
 信用减值损失(元) -1,677,806.76-894,767.52-11,367,660.482,883,884.91-3,344,510.67-2,958,760.98-7,808,310.94
三、其他经营收益
 加:公允价值变动收益(元) 9,893,926.749,293,058.953,363,643.0827,706,690.413,552,303.76-8,117,924.189,527,403.11
 加:投资收益(元) 2,384,663.455,001,731.024,204,435.812,290,535.9779,563.121,605,108.254,659,569.00
 资产处置收益(元) 138,120.593,348,326.57-6,081.72115,948.86-311,384.93-846,551.64
 其他收益(元) 3,575,586.9113,121,404.47796,950.384,407,302.291,316,287.977,410,391.10576,469.16
 营业利润平衡项目(元) -------0.01
四、营业利润(元) 84,732,828.6594,720,685.6547,328,962.3782,479,357.4538,025,982.8144,821,152.0446,254,815.88
 加:营业外收入(元) 69.5979,742.34100,000.1710,107.78-13,132.77842.15
 减:营业外支出(元) 563,818.982,809,063.19271,695.4013,958.84325,193.0713,627,379.39200,109.35
五、利润总额(元) 84,169,079.2691,991,364.8047,157,267.1482,475,506.3937,700,789.7431,206,905.4246,055,548.68
 减:所得税费用(元) 10,158,497.8713,101,114.732,512,937.473,441,218.897,281,323.31716,180.515,719,419.35
六、净利润(元) 74,010,581.3978,890,250.0744,644,329.6779,034,287.5030,419,466.4330,490,724.9140,336,129.33
(一)按经营持续性分类
  持续经营净利润(元) 74,010,581.3978,890,250.0744,644,329.6779,034,287.5030,419,466.4330,490,724.9140,336,129.33
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 73,646,995.6679,090,495.5244,788,913.6279,010,495.1630,383,843.9830,649,350.0840,532,500.99
  少数股东损益(元) 363,585.73-200,245.45-144,583.9523,792.3435,622.45-158,625.17-196,371.66
 扣除非经常性损益后的净利润(元) 61,007,615.0055,544,696.2437,777,315.3650,331,814.2026,459,823.3341,255,535.3528,875,915.88
七、每股收益
 一、基本每股收益(元) 0.931.000.561.000.380.150.75
 二、稀释每股收益(元) 0.931.000.561.000.380.150.75
八、其他综合收益(元) -2,126,660.52497,180.88151,351.08-1,516,274.46-874,674.365,039,229.71-280,655.17
 归属于母公司股东的其他综合收益(元) -2,116,400.31493,378.33144,607.76-1,518,115.99-873,098.475,094,044.91-339,700.28
 归属于少数股东的其他综合收益(元) -10,260.213,802.556,743.321,841.53-1,575.89-54,815.2059,045.11
九、综合收益总额(元) 71,883,920.8779,387,430.9544,795,680.7577,518,013.0429,544,792.0735,529,954.6240,055,474.16
 归属于母公司所有者的综合收益总额(元) 71,530,595.3579,583,873.8544,933,521.3877,492,379.1729,510,745.5135,743,394.9940,192,800.71
 归属于少数股东的综合收益总额(元) 353,325.52-196,442.90-137,840.6325,633.8734,046.56-213,440.37-137,326.55
公告日期 2024-10-312024-08-312024-04-272024-04-272023-10-312023-08-292023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院